- Markets
- Healthcare
- KILITCH
KILITCH
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Kilitch Drugs (India) Unit Won Tender For $9.1 Mln
Feb 23 (Reuters) - Kilitch Drugs (India) Ltd KIDI.NS:
UNIT WON TENDER ISSUED BY FEDERAL DEMOCRATIC REPUBLIC OF ETHIOPIA PHARMACEUTICAL SUPPLY SERVICE
UNIT WON TENDER FOR SUPPLY OF PHARMACEUTICALS
CONTRACT FOR $9.1 MILLION
Source text for Eikon: ID:nBSE3FQc2b
Further company coverage: KIDI.NS
(([email protected];))
Feb 23 (Reuters) - Kilitch Drugs (India) Ltd KIDI.NS:
UNIT WON TENDER ISSUED BY FEDERAL DEMOCRATIC REPUBLIC OF ETHIOPIA PHARMACEUTICAL SUPPLY SERVICE
UNIT WON TENDER FOR SUPPLY OF PHARMACEUTICALS
CONTRACT FOR $9.1 MILLION
Source text for Eikon: ID:nBSE3FQc2b
Further company coverage: KIDI.NS
(([email protected];))
Events:
Dividend
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Kilitch Drugs(India) do?
Kilitch Drugs (India) Limited, based in Mumbai, is a pharmaceutical company focusing on manufacturing and marketing antibacterial parenteral formulations including Carbapenems, Cephalosporins, and anti malarials. It transferred some products to Akorn India Pvt. Ltd. in 2012.
Who are the competitors of Kilitch Drugs(India)?
Kilitch Drugs(India) major competitors are Medicamen Biotech, Prevest Denpro, Ind-Swift Lab., Albert David, Medico Remedies, Bharat Parenterals, Jenburkt Pharma. Market Cap of Kilitch Drugs(India) is ₹565 Crs. While the median market cap of its peers are ₹515 Crs.
Is Kilitch Drugs(India) financially stable compared to its competitors?
Kilitch Drugs(India) seems to be less financially stable compared to its competitors. Altman Z score of Kilitch Drugs(India) is 7.77 and is ranked 4 out of its 8 competitors.
Does Kilitch Drugs(India) pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Kilitch Drugs(India) latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Kilitch Drugs(India) allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Accounts Receivable
How strong is Kilitch Drugs(India) balance sheet?
Balance sheet of Kilitch Drugs(India) is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Kilitch Drugs(India) improving?
Yes, profit is increasing. The profit of Kilitch Drugs(India) is ₹18.02 Crs for TTM, ₹14.6 Crs for Mar 2024 and ₹10.45 Crs for Mar 2023.
Is the debt of Kilitch Drugs(India) increasing or decreasing?
Yes, The debt of Kilitch Drugs(India) is increasing. Latest debt of Kilitch Drugs(India) is ₹26.14 Crs as of Sep-24. This is greater than Mar-24 when it was -₹7.63 Crs.
Is Kilitch Drugs(India) stock expensive?
Kilitch Drugs(India) is not expensive. Latest PE of Kilitch Drugs(India) is 28.93, while 3 year average PE is 56.03. Also latest EV/EBITDA of Kilitch Drugs(India) is 25.09 while 3yr average is 32.37.
Has the share price of Kilitch Drugs(India) grown faster than its competition?
Kilitch Drugs(India) has given better returns compared to its competitors. Kilitch Drugs(India) has grown at ~21.38% over the last 3yrs while peers have grown at a median rate of 13.95%
Is the promoter bullish about Kilitch Drugs(India)?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Kilitch Drugs(India) is 69.23% and last quarter promoter holding is 69.23%.
Are mutual funds buying/selling Kilitch Drugs(India)?
There is Insufficient data to gauge this.